Why QuidelOrtho (QDEL) is a Top Growth Stock for the Long-Term

Company Overview - QuidelOrtho Corporation, based in San Diego, CA, specializes in in-vitro diagnostics technologies for point-of-care settings, clinical labs, and transfusion medicine, selling products directly to end users and distributors [11] Investment Ratings - QuidelOrtho is currently rated 3 (Hold) on the Zacks Rank, with a VGM Score of A, indicating a solid position in the market [12] - The company has a Growth Style Score of A, forecasting a year-over-year earnings growth of 27% for the current fiscal year [12] Earnings Estimates - Two analysts have revised their earnings estimates upwards in the last 60 days for fiscal 2025, with the Zacks Consensus Estimate increasing by $0.01 to$2.35 per share [12] - QuidelOrtho boasts an average earnings surprise of 70.8%, suggesting strong performance relative to expectations [12] Investment Potential - With a solid Zacks Rank and top-tier Growth and VGM Style Scores, QuidelOrtho is recommended for investors looking for growth opportunities [13]